Please assess the completion status of the following clinical trial:

Trial Title: Intermittent Preventive Treatment Versus Scheduled Screening and Treatment of Malaria in Pregnancy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Presence of a first or second pregnancy.~2. Gestation between 16 to 30 weeks inclusive at first booking as determined by symphysio-fundal measurements.~3. Provision of informed consent to join the trial.~4. Residence in the study area and intention to stay in the area for the duration of the pregnancy.~Exclusion Criteria:~1. Absence of informed consent.~2. An intention to leave the study area before delivery.~3. A history of sensitivity to sulphonamides.~4. Clinical AIDS or known HIV positivity.~5. Presence of any systemic illness likely to interfere with interpretation of the results of the trial.

- Gender: FEMALE
- Minimum Age: 16 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- IPTp with SP (Type: ACTIVE_COMPARATOR): Study women will receive at least two doses of SP during their pregnancy, one at each of the recommended ante-natal visits during the 2nd and 3rd trimester.
- IST using RDTs (Type: EXPERIMENTAL): Scheduled intermittent screening using rapid diagnostic tests and treatment of those who are RDT positive during ante-natal clinic visits in the 2nd and 3rd trimester.

Based on this trial design, predict the completion outcome and termination type (if applicable).